Canada Breast Cancer Therapeutics Market: Segmented By Therapy (Chemotherapy, Immunotherapy, Hormone therapy, Targeted therapy, Radiation therapy, Surgery), By Cancer Type (hormone receptor, HER2+), and By Distribution Channel (Hospital Pharmacies, Ambulatory Surgical Centres, Retail and Online pharmacies)- Growth, Trends, and Forecasts (2019 – 2028)
Canada’s Breast Cancer Therapeutics market size stood at around USD XX billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 8.8% during the forecast period (2019-2028).
Canada’s breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 8.8% during the forecast period. In Canada 1 in 8 women are diagnosed with breast cancer in their lifetime, and over 25,000 Canadian women diagnosed each year. Breast cancer accounts for approximately 25% of new cases of cancer and 13% of all cancer deaths in Canadian women. The factors that enable the growth of the market include the prevalence of breast cancer and the initiative by the government and private organizations. Breast cancer is the second leading cause of mortality in Canada. The incidence rate of breast cancer in Canada is increasing with the increase in years.
Market Driving Factors
An increase in the prevalence of Breast cancer, growth in awareness about the availability of cancer treatments, growing healthcare spending for cancer and the launch of technologically advanced therapeutics are predominantly driving the market growth. the advancement of cancer drug research owing to targeted therapies and personalized medicines hold promising opportunities for pharmaceutical, bio-pharmaceutical, and biotechnology companies engaged in developing cancer drugs. However, the higher cost involved in new drug development coupled with adverse effects associated with anti-cancer drug therapies is projected to restrain the growth of the Canada Breast Cancer drug market.
1. Canada Breast Cancer Therapeutics Market Overview……………………………… A. Market Size 2. Market Driving Factors……………………….…………………………….…………. A. Rising prevalence of Breast cancer B. Growing healthcare spending for cancer C. Launch of technologically advanced therapeutics 3. Breast Cancer Stages A. Stage 0 B. Stage 1 C. Stage 2 D. Stage 3 E. Stage 4 4. Breast Cancer Therapeutics Market Segmentation………………………………… A. By Therapy a. Chemotherapy b. Immunotherapy c. Hormone therapy d. Targeted therapy e. Radiation therapy f. Surgery B. By Cancer Type a. hormone receptor b. HER2+ C. By Distribution Channel a. Hospital pharmacies b. Ambulatory Surgical Centres c. Retail and Online pharmacies 5. Breast Cancer Major Products Market Share………………………………………. A. Market Analysis, Insights and Forecast – By Revenue 6. Competitive Landscape………………………………………………………………… A. Major Players B. Products in Pipeline 7. Key Company Profiles…………………………………………………………………. A. Eli Lilly Company overview, Product & Services, Strategies & Financials B. Roche Company overview, Product & Services, Strategies & Financials C. AbbVie Company overview, Product & Services, Strategies & Financials 8. Healthcare Policies and Regulatory Landscape…………………………………… A. Policy changes and Reimbursement scenario 9. Factors Driving Future Growth………………………………………………………… A. New Trends and Development of Dermatology drug market B. Future Opportunities 10. Conclusion
Canada’s breast cancer therapeutics market can be segmented based on the type of therapies as Chemotherapy, Hormone therapy, Targeted therapy, Radiation therapy, and Surgery. Among all therapies, the chemotherapy market held the largest market share in the Canadian breast cancer therapeutics market. The types of chemotherapy include Neoadjuvant Chemotherapy and Adjuvant Chemotherapy. Neoadjuvant treatment is given before giving any other treatments such as surgery. It may include chemotherapy, radiation therapy, or hormone therapy. Adjuvant treatment is given to destroy cancer cells left behind after surgery and reduce the risk that cancer will come back.
By Cancer Type:
Based on the cancer type, the market is segmented into the hormone receptor and HER2+. The hormone receptor segment is likely to dominate the market during the forecast period because of the rising volume of breast cancer patients belonging to this type of cancer.
By Distribution Channel:
Canada’s oncology market can also be segmented based on the type of distribution channel as Hospital pharmacies, Ambulatory Surgical Centres, Retail pharmacies, Online pharmacies. The hospital pharmacies segment is projected to account for a higher share because of the dependency of patients on these pharmacies for the administration of therapies, such as chemotherapy.
The market players are considerably contributing to the market growth by the adoption of various strategies including new product launches, mergers, and acquisitions, collaborations with the government, and technological advancements to stay competitive in the market. Recently Health Canada approved Verzenio (abemaciclib) developed by Eli Lilly for the treatment of metastatic breast cancer. Roche has also announced that Health Canada has approved its new medicine Tecentriq® (atezolizumab) in combination with chemotherapy for the treatment of adult patients with unresectable, locally advanced, or metastatic triple-negative breast cancer. Other Major Players are AbbVie, Amgen, Astellas Pharma, etc.
Insights10 will provide you reports within 10 key parameters which are:
Market growth drivers & restraints
Epidemiology or disease type
Key company profiles
Healthcare policies & regulatory framework
Factors driving future growth
Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Our analysis methodology involves three critical stages:
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Company Websites/Annual Reports
Published Research Reports
Press Releases of Key Market Players
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.
We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model. Two level validation is done and entails finalization of report scope and to way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)
Establishing market drivers and trends
Analyzing regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue / volume
Analyzing current needs and determining penetration to estimate market
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market. Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions. The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
Download Free Sample Report
Share with someone
Inquiry before buying
150+ Analyst and Consultants
Our team of 150+ analyst and consultants carry a rich experience working in Life sciences domain
Insights10 has 13000+ ready available syndicated market research reports
Specialised in Lifesciences Market
One stop solutions for all your Life-sciences market research requirements
This report addresses
Market intelligence to enable effective decision making
Growth opportunities and trend analysis
Historical data & forecasts
Speak to our analyst to know how this research was put together
Add more countries or regions as part of customisation
Understand how this report can have direct impact on your revenue